GenoLogics has announced that Penn State College of Medicine and Penn State Hershey Medical Center have selected Geneus™ and Proteus™ to manage their research informatics needs across multiple labs and multiple science domains.
Both solutions will be installed in multiple core labs within the college and the medical center, and will be instrumental in enabling operational and scientific research excellence.
Proteus and Geneus are robust lab and data management solutions, each purposed for a specific scientific discipline, and they are built on GenoLogics’ configurable lab informatics platform, OMIX, that acts as the ‘central nervous system’ across multiple labs.
“It was crucial for us to choose a solution we can implement quickly across multiple labs, with immediate benefits for our researchers and bioinformaticians. These systems will assist us in becoming an NCI-designated Cancer Center, while enabling our longer term bioinformatics and translational medicine visions,” stated Richard Rauscher, Director of Information Technology for Penn State Cancer Institute.
Penn State Hershey Medical Center will use Geneus and Proteus to manage sample data and workflows in a number of core labs including: functional genomics, molecular genetics, macromolecular, proteomics/mass spectrometry, cell science/flow cytometry, transgenic, microscopy imaging, MRI/NMR, and viral vector cores.
Bruce Stanley, Director, Section of Research Resources at Penn State College of Medicine, commented, “We extensively evaluated a number of LIMS vendors, and we chose GenoLogics because their solutions are deeply purposed and configurable to address our science needs, but based on a common lab informatics platform that we can implement across multiple labs. GenoLogics was able to show us they can easily accommodate the unique needs of our labs and our informatics requirements.”
Because of the open architecture and configurability of the lab informatics platform, Proteus and Geneus seamlessly integrate with a multitude of instruments and software, freeing scientists to use the best tools for their research.
GenoLogics’ lab informatics platform is suited for enabling Penn State Hershey Medical Center’s long term translational medicine initiatives. Geneus and Proteus support information and data transfer requirements between clinical and research domains, and facilitate data integration and interchange with other supporting systems, providing an enabling platform to facilitate translational research.
Geneus and Proteus will support this vision with science-specific features including: genotyping, gene expression, and quality control modules; peptide centric-results and analysis; automated data capture; protein search results analysis; and automated bioinformatics pipelining. These solutions also provide a central repository of data that will greatly ease collaboration between labs. The overall solution for Penn State includes genomics and proteomics purposed modules, and can also be configured to accommodate other application areas.
Michael Ball, GenoLogics CEO, stated “I am very excited that Penn State Hershey has chosen GenoLogics – we’re confident our solutions are ideal for linking their labs, managing their data and accommodating the breadth of sciences included in their research areas. We also look forward to working with them in the future to implement our research LIMS solution as a mechanism to enable their translational research initiatives.”